Introduction {#sec1}
============

Colorectal cancer (CRC) is common, with a worldwide incidence estimated at more than 1 million cases annually. Surgery remains the most effective curative treatment for CRC, but the risk of recurrence is high. Only 70% of cases are resectable, of which 75% are curable \[[@cit0001], [@cit0002]\]. Thus, many patients receive adjuvant chemotherapy. Therefore, the search for chemotherapeutic agents for the treatment of CRC is highly warranted \[[@cit0003], [@cit0004]\]. Many natural products can act as strong chemopreventive/therapeutic agents against CRC \[[@cit0005]--[@cit0008]\].

Inositol-6 phosphate (IP~6~) is a simple ringed carbohydrate with six phosphate groups attached to each carbon. It is a major form of phosphorylated inositol present in food, constituting 1--5% by weight of most cereals, nuts, oilseed, legumes, and grains. Inositol 6 phosphate, which occurs at 9.5--14.5% by weight in rice bran, possesses various health benefits \[[@cit0009]\]. Both *in vivo* and *in vitro* experiments provide convincing evidence for the anti-carcinogenic effects of IP~6~ \[[@cit0010]\]. Our own studies have shown that IP~6~ is effective against azoxymethane-induced CRC. It reduces the incidence of aberrant crypt foci and tumor formation \[[@cit0011]\]. It inhibits cell proliferation, arrests the cell cycle at the G~2~M phase, and induces apoptosis in hepatocellular carcinoma \[[@cit0012], [@cit0013]\].

Mammalian target of rapamycin (mTOR) is a vital signaling pathway involved in many cellular processes. It regulates many intracellular signaling molecules to provide energy resources to the cell. The involvement of mTOR signaling in CRC is well known. Similarly, the inhibition of mTOR signaling leads to the inhibition of CRC cell growth *in vitro* and adenoma formation *in vivo* \[[@cit0014]--[@cit0016]\]. Autophagy is a physiological process that allows the degradation of cytoplasmic contents, including unfolded proteins and membranous organelles, under certain stress conditions. This serves as a temporary survival mechanism \[[@cit0017]\]. mTOR1 is oncogenic and facilitates intracellular signaling for the translation of proteins required by the cell; it is also used by cancer cells for survival and growth. mTOR1 is a negative regulator of autophagy via binding to the Atg13-ULK1/2-FIP200 complex, phosphorylation of the complex components, and inhibition of autophagy. Nutrient deprivation results in the release of mTOR1 and dephosphorylation of ULK1/2 and Atg13 and hence facilitates the activation of autophagy \[[@cit0016]\]. Inositol 6 phosphate is considered a potent chemotherapeutic agent, and the mechanism of killing HT-29 human colon cancer cells is still not clear. We hypothesized that IP~6~ inhibits mTOR signaling, leading to the activation of autophagy-mediated death in HT-29 colon cancer cells.

Material and methods {#sec2}
====================

Cell culture {#sec2.1}
------------

The human colorectal cancer cell line HT-29 was purchased from the American Type Culture Collection (ATCC) (Manassas, VA, USA) and the cells were grown in Dulbecco's Modified Eagle Medium with the following supplements: 10% (v/v) fetal bovine serum, 100 IU/ml penicillin, and 100 μg/ml streptomycin. Cells were grown in a sterile cell culture flask at 37°C in the presence of 5% carbon dioxide (CO~2~).

Cell viability assay {#sec2.2}
--------------------

Cells were seeded and cultured with various doses of IP~6~ (2.5--20 μg/ml) for 24 h. Culture media were replaced with 0.05% MTT solution and incubated at 37°C for 2 h. Dimethyl sulfoxide was added after the removal of the MTT solution. After a brief incubation period, the absorbance of the solution was measured using a microplate reader.

Immunofluorescence {#sec2.3}
------------------

Cells were grown to 60--70% confluence on glass coverslips in 6-well plates and treated with IP~6~ for 16 h. After treatment, cells were washed with phosphate-buffered saline (PBS), fixed with acetone:methanol (--20°C, 10 min), and blocked in 10% nonimmune goat serum (Sigma-Aldrich, St. Louis, MO, USA) for 1 h. LC3-II (NOVUS Biologicals, Littleton, CO, USA) antibody was applied (1 h), followed by incubation (1 h) with Alexa Fluor 594 F(ab')2 fragment of goat anti-mouse IgG (Invitrogen, Carlsbad, CA, USA). Nuclei were stained with Hoechst. Then, the slides were assessed using a fluorescent microscope.

Transmission electron microscopy {#sec2.4}
--------------------------------

Samples were prepared for transmission electron microscopy according to a published protocol \[[@cit0018]\]. Briefly, the cells were fixed in 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 30 min, post-fixed in 1% osmium tetroxide in the same buffer for 30 min, dehydrated in graded ethanol, washed with propylene oxide, embedded in Epon, and then sectioned using an ultra-microtome at a thickness of 90 nm. Thin sections were stained with 5% uranyl acetate and 5% lead citrate and then examined using a transmission electron microscope at 75 kV.

Autophagy detection {#sec2.5}
-------------------

Autophagy is a lysosomal degradation pathway for cytoplasmic material. The acidic intracellular compartments were visualized by acridine orange (AO) staining. After incubation, cells were washed with PBS and stained with 1 mg/ml AO for 15 min at 37ºC. Subsequently, cells were washed and analyzed under an inverted fluorescent microscope. Fluorescence microscopy was performed using 490-nm band-pass blue excitation filters and a 515-nm long-pass barrier filter. Owing to differences in acidity, autophagic lysosomes appeared as orange/red fluorescent cytoplasmic vesicles, while the cytoplasm and nucleolus were green.

Determination of apoptosis by annexin V-FITC {#sec2.6}
--------------------------------------------

HT-29 colon cancer cells were seeded in 96-well plates at 2 × 10^5^ cells per well for 16 h, treated with 10 μg/ml IP~6~ or control, and incubated at 37°C for 24 and 48 h. The harvested cells were labeled with a mixture of 1 : 1 ratio of annexin V-FITC (20 μg/ml) and propidium iodide (50 μg/ml) at 37°C for 30 min in darkness. Then, the cells were analyzed for the expression of annexin V, using a high-throughput screening machine (Thermo Scientific, Waltham, MA, USA).

Western blot analysis {#sec2.7}
---------------------

Western blot analysis was performed to detect mTOR pathway components (p70-S6K, Total p-70-S6 Kinase, p-4EBP1, and Total-4-EBP1) and autophagy markers (Beclin 1 and LC3-II) \[[@cit0019]\]. Cells were lysed in ice-cold, whole-cell lysis buffer. For cytoplasmic and nuclear extraction, cells were lysed in cytoplasmic lysis buffer and nuclei were pelleted and lysed in hypotonic buffer (30 min). The protein concentration was measured by the Bradford method. Lysates were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a polyvinylidene difluoride membrane and blocked in 4% nonfat milk with 0.3% Tween 20. Antigen-antibody complexes were visualized by chemiluminescence.

Transfection of LC-3 siRNA {#sec2.8}
--------------------------

The LC3 SiRNA Kit was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and used according to the instructions provided in the kit. HT-29 cells were seeded at a concentration of 2 × 10^5^ cells 24 h prior to transfection in a 6-well plate. After 24 h, the medium was discarded and cells were washed three times with PBS. Fetal bovine serum-free medium with 5% penicillin/streptomycin was added to the cells. Three transfection complexes were prepared (resulting in final concentrations of LC3 siRNA/control siRNA of 0.5 μg/well) 10 min before they were applied to the medium. The cells were treated with 100 μl of a transfection complex. Cells were incubated for 6 h and supplemented with 1 ml of normal growth medium containing 2 times the normal concentration of serum and antibiotics (2× normal growth medium), without removing the transfection mixture. The cells were incubated for an additional 18--24 h and the medium was aspirated and replaced with fresh 1× normal growth medium. These cells were used to identify the cell viability and to analyze the expression of LC3-II. Each experimental condition was repeated in triplicate.

Statistical analysis {#sec2.9}
--------------------

At least 3 independent biological replicates were performed for all experiments. For western blots, one representative blot is shown in the Figures. Quantification was performed from 3 independent experiments and the results are expressed as means ± SD. Statistical evaluations were performed by Student's *t*-test for pairwise comparisons. *P* \< 0.05 was considered statistically significant.

Results {#sec3}
=======

Inositol-6 phosphate is cytotoxic to HT-29 colon cancer cells {#sec3.1}
-------------------------------------------------------------

Cell viability was analyzed by MTT assay. HT-29 colon cancer cells were treated with IP~6~ at various concentrations, i.e., 0, 2.5, 5, 7.5, 10, 15, and 20 μg/ml, for 24 h. We found that the IC~50~ was 10 μg/ml ([Figure 1](#f0001){ref-type="fig"}). Accordingly, subsequent experiments were performed using a concentration of 10 μg/ml.

![Inositol-6 phosphate (IP~6~) is cytotoxic to HT-29 colon cancer cells. MTT cell viability assay. Inositol-6 phosphate showed IC~50~ at the dose of 10 μg/ml. The detailed methods are described in the Material and methods section\
Statistical significance compared with the untreated group. The statistical significance at \*p \< 0.05 and \*\*p \< 0.01](AMS-14-33250-g001){#f0001}

Inositol-6 phosphate inhibits Akt signaling in HT-29 colon cancer cells {#sec3.2}
-----------------------------------------------------------------------

The results of western blot analysis of Akt signaling are summarized in [Figure 2](#f0002){ref-type="fig"}. Administration of IP~6~ to HT-29 colon cancer cells at doses of 10 and 15 μg/ml for 3 h resulted in decreased expression of p-Akt compared to the control cells. We did not detect alterations in the expression of total-Akt. We further confirmed the expression of p-Akt in HT-29 colon cancer cells by immunofluorescence. We obtained results similar to those in the western blot analysis. Accordingly, we confirmed that IP~6~ inhibits the expression of p-Akt in HT-29 colon cancer cells.

![Inositol-6 phosphate (IP~6~) inhibits expression of p-Akt. **A** -- Western blot analysis of p-Akt. Incubation of HT-29 cells with IP~6~ tends to suppress the expression of p-Akt in less than 3 h compared with control cells. The quantification of western blots using ImageJ software was illustrated as fold change. **B** -- Immunofluorescent analysis of p-Akt. The detailed methodology is described in the Material and Methods section (60× magnification). Similar results were obtained as those in the western blot analysis\
Statistical significance compared with the untreated group. The statistical significance at \*p \< 0.05 and \*\*p \< 0.01](AMS-14-33250-g002){#f0002}

Inositol-6 phosphate inhibits mTOR signaling in HT-29 colon cancer cells {#sec3.3}
------------------------------------------------------------------------

We next assessed the effect of IP~6~ on downstream targets of mTOR. It is well established that activated mTOR transmits its signal to activate P70-S6 kinase (S6K70) and negatively regulates eukaryotic translation initiation factor 4E-binding protein 1 (4EBP1), which binds to and inhibits eukaryotic translation initiation factor (eIF) 4E \[[@cit0020]\]. Among several phosphorylation sites of P70-S6K, phosphorylation at T^421/S424^ is necessary for its activation and phosphorylation at T^389^ is required for full kinase function \[[@cit0021]\]. The activation of S6K70 was significantly decreased after IP~6~ treatment ([Figure 3 A](#f0003){ref-type="fig"}). The total P70-S6K and total 4EBP1 levels were unaltered in all groups. We thus found that IP~6~ significantly inhibits the mTOR pathway in HT-29 colon cancer cells.

![Inositol-6 phosphate (IP~6~) suppresses expression of downstream targets of mTOR signaling. **A** -- Western blot analysis of p-Akt. Incubation of HT-29 cells with IP~6~ tends to suppress the expression of downstream targets of mTOR signaling, such as p70-S6K and p-4EBP1, in less than 3 h. We also noted that the total forms of both p70-S6K and 4EBP1 were unaltered by treatment with IP~6~. The quantification of western blots using ImageJ software was illustrated as fold change. **B** -- Immunofluorescent analysis of p-p70S6K. The detailed methodology is described in the Material and methods section (40× magnification). Similar results were obtained as those in the western blot analysis](AMS-14-33250-g003){#f0003}

Inositol-6 phosphate induces autophagy in HT-29 colon cancer cells {#sec3.4}
------------------------------------------------------------------

We determined the effect of IP~6~ on the formation of acidic vesicular organelles in HT-29 cells by fluorescent microscopy after staining with AO. As shown in Figure 4 A, IP~6~ treatment increased AO staining in acidic vesicular organelles in HT-29 in a time-dependent manner. At 10 μg/ml IP~6~, the number of AO-stained cells increased dramatically when compared to that of control cells. When these IP~6~-treated cells were examined under a transmission electron microscope, double- or multi-membrane structures containing high-electron-density substances characteristic of autophagosomes and autolysosomes were present ([Figure 3 B](#f0003){ref-type="fig"}). Many autolysosomes were degraded in cells treated with 10 μg/ml IP~6~ for 24 and 48 h ([Figure 3 B](#f0003){ref-type="fig"}).

Inositol-6 phosphate activates LC3-II and Beclin 1 in HT-29 colon cancer cells {#sec3.5}
------------------------------------------------------------------------------

It is known that the Beclin 1 level and LC3 conversion (LC3-I to LC3-II) are selective markers of autophagy \[[@cit0022]\]. As shown in Figure 4 C, IP~6~ treatment markedly increased the expression of Beclin 1 and LC3-II, suggestive of autophagy induction. To further confirm the induction of autophagy by IP~6~, we utilized fluorescence microscopy to examine autophagosome formation in HT-29 cells. The conversion of LC3-I (a soluble form) to LC3-II (a lipidized form) is associated with the membranes of autophagosomes \[[@cit0023]\] and can be detected by the formation of punctate structures. Treatment of cells for 24 h and 48 h with IP~6~ resulted in increased expression of LC3-II in HT-29 colon cancer cells ([Figure 4 D](#f0004){ref-type="fig"}). These findings clearly indicated that IP~6~ induces autophagy by activating the expression of LC3-II in HT-29 colon cancer cells.

![Inositol-6 phosphate (IP~6~) induces autophagy in HT-29 cells. **A** -- Autophagy is a lysosomal degradation pathway for cytoplasmic material. The acidic intracellular compartments were visualized by acridine orange (AO) staining. Cells were treated with 10 μg/ml IP~6~ for 24 and 48 h. After incubation, cells were washed with phosphate-buffered saline and stained with 1 mg/ml AO for 15 min at 37ºC. Subsequently, cells were washed and analyzed under an inverted fluorescent microscope. **B** -- Transmission electron microscopic analysis of HT-29 cells after treatment with IP~6~. When IP~6~-treated cells were examined under a transmission electron microscope, doubleor multimembrane structures containing high-electron-density substances characteristic of autophagosomes and autolysosomes were present. Many autolysosomes were degraded in cells treated with 10 μg/ml IP~6~ for 24 and 48 h. **C** -- Western blot analysis of LC3 and Beclin 1. Incubation of IP~6~ with HT-29 cells resulted in increased expression of LC3-II and Beclin 1. The quantification of western blots using ImageJ software was illustrated as fold change. **D** -- Immunofluorescent analysis of LC3-II. The detailed methodology is described in the Material and methods section (40× magnification). Similar results were obtained as those observed in the western blot analysis](AMS-14-33250-g004){#f0004}

Inositol-6 phosphate-induced cell death is mediated by LC3-II {#sec3.6}
-------------------------------------------------------------

IP~6~-mediated cell viability was observed in HT-29 Mock (Mock SiRNA control) and siRNA-LC3 cells. LC3 silencing prevented IP~6~-induced HT-29 cell death ([Figure 5 A](#f0005){ref-type="fig"}). In HT-29 SiRNA mock cells, IP~6~-induced LC3A expression was blocked ([Figure 5 B](#f0005){ref-type="fig"}). These results confirmed that IP~6~-induced cell death in HT-29 was mediated by the activation of LC3-II.

![](AMS-14-33250-g005){#f0005}

Inositol-6 phosphateinduces apoptosis in HT-29 colon cancer cells {#sec3.7}
-----------------------------------------------------------------

If a natural/synthetic drug source can induce apoptosis, it can be developed as a chemotherapeutic agent \[[@cit0005], [@cit0024], [@cit0025]\]. As shown in [Figure 6](#f0006){ref-type="fig"}, treatment with IP~6~ resulted in an increase in the cell population that was positive for annexin V-FITC staining. Starting at 24--48 h, HT-29 cells underwent apoptosis, as detected by the green fluorescence of annexin V-FITC when compared with that of control cells ([Figure 6](#f0006){ref-type="fig"}). Hence, we confirmed that IP~6~ induces apoptosis, as evidenced by the increased amount of exposed phosphatidylserine.

![](AMS-14-33250-g006){#f0006}

Discussion {#sec4}
==========

Abundant evidence indicates that autophagy plays a vital role in determining cell fate. When subjected to miscellaneous stresses, tumor cells initiate autophagy; nevertheless, the excessive activation of autophagy appears to result in cell death. In our study, we first observed that IP~6~ at a concentration of 2.5 to 20 μg/ml dose-dependently inhibits the viability of HT-29 colon cancer cells ([Figure 1](#f0001){ref-type="fig"}). It is well known that most chemotherapeutic agents are toxic not only to tumor cells, but also to normal cells; thus, these agents produce major side effects. The selective cytotoxicity of IP~6~ against colon cancer cells makes it an attractive candidate for drug development.

mTORC1 plays a key role in protein synthesis regulation via its effectors S6K1 and 4E-BP1. Constitutively activated mTOR signaling has been shown previously in CRC \[[@cit0026]\]. Indeed, several ribosomal proteins are up-regulated in CRC, including the S6K1 target S6 \[[@cit0027]\]. Targeted mTOR inhibition decreases adenoma formation in a mouse familial adenomatous polyposis model \[[@cit0028]\] and also inhibits CRC cell growth. It is also well known that the inhibition of mTOR signaling in CRC activates autophagy \[[@cit0016]\]. In the present study, we showed that IP~6~ inhibits downstream effectors of mTORC1, i.e., P70-S6K1 and 4E-BP1 ([Figure 3](#f0003){ref-type="fig"}). Deletion of P70-S6K1 in mice results in defective ribosomal biogenesis and the disruption of a single ribosomal protein shuts down ribosomal synthesis \[[@cit0029]\]. We confirmed that IP~6~ inhibits Akt/mTOR signaling in HT-29 colon cancer cells.

mTOR negatively regulates autophagy, and therefore we assessed the effects of IP~6~ on autophagy \[[@cit0029], [@cit0030]\]. Autophagy is a physiological process that allows the degradation of cytoplasmic contents, including unfolded proteins and membranous organelles, under certain stress conditions. This functions as a temporary survival mechanism for cells. Certain cellular stresses, such as oxidative stress, nutrient starvation, misfolded protein accumulation, and irradiation, could induce autophagy. Once initiated, the process delivers cytoplasmic materials to lysosomes via double membrane organelles termed autophagosomes, which enclose a portion of the cytoplasm and intracellular organelles \[[@cit0031]\]. However, recent studies have shown that autophagy is also a cell death mechanism and is a response to various anticancer therapies in many kinds of cancer cells \[[@cit0032], [@cit0033]\]. Our results showed that IP~6~ induces autophagy, as confirmed by the increased expression of LC3-II and Beclin 1 ([Figure 4](#f0004){ref-type="fig"}). LC3 is a commonly used autophagy marker, and its processed form, LC3-I, resides in the cytoplasm. After autophagy induction, LC3-II, the conjugated form of LC3, associates with autophagosomes. However, an increase in autophagosomes alone, suggested by increased LC3-II levels, does not necessarily indicate increased autophagy \[[@cit0034]\].

We also confirmed that IP~6~ induces apoptosis, based on the increased expression of annexin V ([Figure 6](#f0006){ref-type="fig"}). Apoptosis is characterized by cell shrinkage, chromatin condensation, DNA fragmentation, and the activation of specific cysteine proteases known as caspases. We previously showed that rice bran IP~6~ induces apoptosis by regulating pro- and anti-apoptotic Bax and Bcl-xl, as well as via the activation of caspase-3 and -8 \[[@cit0035], [@cit0036]\]. Inositol-6 phosphate can also induce mitochondrial-mediated apoptosis in HT-29 cells.

In conclusion, the Akt/mTOR pathway plays an essential role in the survival of colon cancer cells. We demonstrated that IP~6~ inhibits the Akt/mTOR signaling pathway in HT-29 cells. We previously showed that IP~6~ induces apoptosis in colon cancer cells. In this study, we further elucidated the mechanism by which IP~6~ causes autophagy, i.e., by activating the expression of LC3-II and Beclin 1. We therefore suggest that IP~6~ has the potential to be developed as an anti-cancer remedy.
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